Acadian Asset Management LLC Neoleukin Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.69 - $1.33 $14,619 - $28,180	21,188 New	21,188 $13,000
Q2 2022 Aug 09, 2022	SELL	$0.92 - $2.25 $7,077 - $17,309	-7,693 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.72 - $5.23 $27,024 - $82,173	-15,712 Reduced 67.13%	7,693 $14,000
Q4 2021 Feb 10, 2022	BUY	$4.65 - $7.75 $108,833 - $181,388	23,405 New	23,405 $112,000
Q3 2020 Nov 09, 2020	SELL	$9.68 - $17.01 $155,199 - $272,721	-16,033 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$9.95 - $17.05 $2.6 Million - $4.46 Million	-261,600 Reduced 94.23%	16,033 $266,000
Q1 2020 May 11, 2020	SELL	$6.12 - $13.64 $1.22 Million - $2.73 Million	-200,107 Reduced 41.89%	277,633 $3.16 Million
Q4 2019 Feb 06, 2020	SELL	$2.65 - $12.72 $349,564 - $1.68 Million	-131,911 Reduced 21.64%	477,740 $5.89 Million
Q3 2019 Nov 07, 2019	BUY	$2.33 - $3.76 $1.42 Million - $2.29 Million	609,651 New	609,651 $1.74 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.